These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 29096054)

  • 1. Comparison of ferumoxytol-based cerebral blood volume estimates using quantitative R
    Rivera-Rivera LA; Schubert T; Knobloch G; Turski PA; Wieben O; Reeder SB; Johnson KM
    Magn Reson Med; 2018 Jun; 79(6):3072-3081. PubMed ID: 29096054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurements of cerebral blood volume using quantitative susceptibility mapping, R
    Rivera-Rivera LA; Schubert T; Johnson KM
    NMR Biomed; 2019 Dec; 32(12):e4175. PubMed ID: 31482602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of microvascular cerebral blood volume changes over the cardiac cycle with ferumoxytol-enhanced T
    Rivera-Rivera LA; Johnson KM; Turski PA; Wieben O; Schubert T
    Magn Reson Med; 2019 Jun; 81(6):3588-3598. PubMed ID: 30756424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of care.
    Varallyay CG; Nesbit E; Horvath A; Varallyay P; Fu R; Gahramanov S; Muldoon LL; Li X; Rooney WD; Neuwelt EA
    J Magn Reson Imaging; 2018 Aug; 48(2):441-448. PubMed ID: 29314418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution cerebral blood volume imaging in humans using the blood pool contrast agent ferumoxytol.
    Christen T; Ni W; Qiu D; Schmiedeskamp H; Bammer R; Moseley M; Zaharchuk G
    Magn Reson Med; 2013 Sep; 70(3):705-10. PubMed ID: 23001902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental estimates of the constants relating signal change to contrast concentration for cerebral blood volume by T2* MRI.
    Newman GC; Hospod FE; Patlak CS; Fain SE; Pulfer KA; Cook TD; O'Sullivan F
    J Cereb Blood Flow Metab; 2006 Jun; 26(6):760-70. PubMed ID: 16319833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myocardial microcirculation in humans--new approaches using MRI].
    Wacker CM; Bauer WR
    Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxivity of Ferumoxytol at 1.5 T and 3.0 T.
    Knobloch G; Colgan T; Wiens CN; Wang X; Schubert T; Hernando D; Sharma SD; Reeder SB
    Invest Radiol; 2018 May; 53(5):257-263. PubMed ID: 29215401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid simultaneous estimation of relaxation rates using multi-echo, multi-contrast MRI.
    Keeling EG; Sisco NJ; McElvogue MM; Borazanci A; Dortch RD; Stokes AM
    Magn Reson Imaging; 2024 Oct; 112():116-127. PubMed ID: 38971264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain Iron Assessment after Ferumoxytol-enhanced MRI in Children and Young Adults with Arteriovenous Malformations: A Case-Control Study.
    Iv M; Ng NN; Nair S; Zhang Y; Lavezo J; Cheshier SH; Holdsworth SJ; Moseley ME; Rosenberg J; Grant GA; Yeom KW
    Radiology; 2020 Nov; 297(2):438-446. PubMed ID: 32930651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
    Neuwelt EA; Várallyay CG; Manninger S; Solymosi D; Haluska M; Hunt MA; Nesbit G; Stevens A; Jerosch-Herold M; Jacobs PM; Hoffman JM
    Neurosurgery; 2007 Apr; 60(4):601-11; discussion 611-2. PubMed ID: 17415196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of MRI contrast agent concentration by quantitative susceptibility mapping (QSM): application to estimation of cerebral blood volume during steady state.
    Lind E; Knutsson L; Kämpe R; Ståhlberg F; Wirestam R
    MAGMA; 2017 Dec; 30(6):555-566. PubMed ID: 28631203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferumoxytol enhanced resting state fMRI and relative cerebral blood volume mapping in normal human brain.
    D'Arceuil H; Coimbra A; Triano P; Dougherty M; Mello J; Moseley M; Glover G; Lansberg M; Blankenberg F
    Neuroimage; 2013 Dec; 83():200-9. PubMed ID: 23831413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution steady-state cerebral blood volume maps in patients with central nervous system neoplasms using ferumoxytol, a superparamagnetic iron oxide nanoparticle.
    Varallyay CG; Nesbit E; Fu R; Gahramanov S; Moloney B; Earl E; Muldoon LL; Li X; Rooney WD; Neuwelt EA
    J Cereb Blood Flow Metab; 2013 May; 33(5):780-6. PubMed ID: 23486297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic assessment of multi-echo dynamic susceptibility contrast MRI using a digital reference object.
    Stokes AM; Semmineh NB; Nespodzany A; Bell LC; Quarles CC
    Magn Reson Med; 2020 Jan; 83(1):109-123. PubMed ID: 31400035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral blood volume measurements by rapid contrast infusion and T2*-weighted echo planar MRI.
    Tudorica A; Fang Li H; Hospod F; Delucia-Deranja E; Huang W; Patlak CS; Newman GC
    Magn Reson Med; 2002 Jun; 47(6):1145-57. PubMed ID: 12111961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of quantitative dynamic susceptibility-contrast MRI perfusion estimates obtained using different contrast-agent administration schemes at 3T.
    Wirestam R; Thilmann O; Knutsson L; Björkman-Burtscher IM; Larsson EM; Ståhlberg F
    Eur J Radiol; 2010 Jul; 75(1):e86-91. PubMed ID: 19720489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental ferumoxytol artifacts in clinical brain MR imaging.
    Bowser BA; Campeau NG; Carr CM; Diehn FE; McDonald JS; Miller GM; Kaufmann TJ
    Neuroradiology; 2016 Nov; 58(11):1087-1091. PubMed ID: 27704163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative measurement of cerebral blood volume using velocity-selective pulse trains.
    Liu D; Xu F; Lin DD; van Zijl PCM; Qin Q
    Magn Reson Med; 2017 Jan; 77(1):92-101. PubMed ID: 27797101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an fMRI USPIO-based assay in healthy human volunteers.
    Baumgartner R; Cho W; Coimbra A; Chen C; Wang Z; Struyk A; Venketasubramanian N; Low M; Gargano C; Zhao F; Williams D; Reese T; Seah S; Feng D; Apreleva S; Petersen E; Evelhoch JL
    J Magn Reson Imaging; 2017 Jul; 46(1):124-133. PubMed ID: 27775841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.